Publicacións (120) Publicacións nas que participase algún/ha investigador/a Ver datos de investigación referenciados.

filter_list Cancer Research

2024

  1. Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population

    Cancer Chemotherapy and Pharmacology, Vol. 94, Núm. 3, pp. 387-395

  2. CARTAR: a comprehensive web tool for identifying potential targets in chimeric antigen receptor therapies using TCGA and GTEx data

    Briefings in Bioinformatics, Vol. 25, Núm. 4

  3. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63

    Scientific Reports, Vol. 14, Núm. 1

2023

  1. A Genome-Wide Association Study of Small Cell Lung Cancer

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 645-650

  2. BMPR2 as a Novel Predisposition Gene for Hereditary Colorectal Polyposis

    Gastroenterology, Vol. 165, Núm. 1, pp. 162-172.e5

  3. NAD pool as an antitumor target against cancer stem cells in head and neck cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 42, Núm. 1

2022

  1. Colorectal cancer. Genetic variants in BMP signaling pathway and ancestry in the Mexican population

    Gaceta Medica de Mexico, Vol. 158, Núm. 6, pp. 419-424

  2. PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2

    npj Genomic Medicine, Vol. 7, Núm. 1

  3. Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma

    Cancers, Vol. 14, Núm. 22

  4. Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach

    Genes, Vol. 13, Núm. 4

2021

  1. Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture

    Nature Communications, Vol. 12, Núm. 1

  2. Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk

    Journal of the National Cancer Institute, Vol. 113, Núm. 3, pp. 329-337

  3. Discovery of a novel and a rare Kristen rat sarcoma viral oncogene homolog (KRAS) gene mutation in colorectal cancer patients

    Bioengineered, Vol. 12, Núm. 1, pp. 5099-5109

  4. Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer

    Scientific Reports, Vol. 11, Núm. 1

  5. Genetic susceptibility to CRC

    Foundations of Colorectal Cancer (Elsevier), pp. 513-518

  6. LIPG endothelial lipase and breast cancer risk by subtypes

    Scientific Reports, Vol. 11, Núm. 1

  7. Liquid biopsy biomarkers for immunotherapy in non-small cell lung carcinoma: Lessons learned and the road ahead

    Journal of Personalized Medicine, Vol. 11, Núm. 10

  8. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy

    Cancer Chemotherapy and Pharmacology, Vol. 88, Núm. 5, pp. 813-823

  9. SDCBP modulates stemness and chemoresistance in head and neck squamous cell carcinoma through src activation

    Cancers, Vol. 13, Núm. 19

  10. Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity

    Cancer Research, Vol. 81, Núm. 19, pp. 4901-4909